- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Recombinant DNA (rDNA) Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Recombinant DNA (rDNA) Technology sales will be xx in 2020 from Recombinant DNA (rDNA) Technology million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Recombinant DNA (rDNA) Technology market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Recombinant DNA (rDNA) Technology industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Recombinant DNA (rDNA) Technology and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Recombinant DNA (rDNA) Technology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant DNA (rDNA) Technology market has been segmented into:
Expression System
Cloning Vector
By Application, Recombinant DNA (rDNA) Technology has been segmented into:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant DNA (rDNA) Technology market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant DNA (rDNA) Technology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant DNA (rDNA) Technology market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant DNA (rDNA) Technology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant DNA (rDNA) Technology Market Share Analysis
Recombinant DNA (rDNA) Technology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant DNA (rDNA) Technology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant DNA (rDNA) Technology sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant DNA (rDNA) Technology are:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Eli Lilly and Company
Novartis AG
Profacgen
Novo Nordisk A/S
Amgen Inc
Biocon
Pfizer Inc
GenScript
Sanofi
Horizon Discovery Group PLC
GlaxoSmithKline plc
Monsanto Company
New England Biolabs.
Cibus
Among other players domestic and global, Recombinant DNA (rDNA) Technology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Recombinant DNA (rDNA) Technology Market Overview
1.1 Product Overview and Scope of Recombinant DNA (rDNA) Technology
1.2 Classification of Recombinant DNA (rDNA) Technology by Component
1.2.1 Global Recombinant DNA (rDNA) Technology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Component in 2019
1.2.3 Expression System
1.2.4 Cloning Vector
1.3 Global Recombinant DNA (rDNA) Technology Market by Application
1.3.1 Overview: Global Recombinant DNA (rDNA) Technology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Global Recombinant DNA (rDNA) Technology Market by Regions
1.4.1 Global Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Recombinant DNA (rDNA) Technology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Recombinant DNA (rDNA) Technology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Recombinant DNA (rDNA) Technology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Recombinant DNA (rDNA) Technology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Recombinant DNA (rDNA) Technology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Recombinant DNA (rDNA) Technology Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Recombinant DNA (rDNA) Technology Industry Impact
1.5.1 COVID-19 Potential Implications for the Recombinant DNA (rDNA) Technology
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Recombinant DNA (rDNA) Technology
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
2.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Details
2.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) SWOT Analysis
2.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Product and Services
2.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly and Company SWOT Analysis
2.2.4 Eli Lilly and Company Product and Services
2.2.5 Eli Lilly and Company Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Profacgen
2.4.1 Profacgen Details
2.4.2 Profacgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Profacgen SWOT Analysis
2.4.4 Profacgen Product and Services
2.4.5 Profacgen Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novo Nordisk A/S
2.5.1 Novo Nordisk A/S Details
2.5.2 Novo Nordisk A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novo Nordisk A/S SWOT Analysis
2.5.4 Novo Nordisk A/S Product and Services
2.5.5 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen Inc
2.6.1 Amgen Inc Details
2.6.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen Inc SWOT Analysis
2.6.4 Amgen Inc Product and Services
2.6.5 Amgen Inc Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biocon
2.7.1 Biocon Details
2.7.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biocon SWOT Analysis
2.7.4 Biocon Product and Services
2.7.5 Biocon Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer Inc
2.8.1 Pfizer Inc Details
2.8.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer Inc SWOT Analysis
2.8.4 Pfizer Inc Product and Services
2.8.5 Pfizer Inc Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.9 GenScript
2.9.1 GenScript Details
2.9.2 GenScript Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GenScript SWOT Analysis
2.9.4 GenScript Product and Services
2.9.5 GenScript Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.11 Horizon Discovery Group PLC
2.11.1 Horizon Discovery Group PLC Details
2.11.2 Horizon Discovery Group PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Horizon Discovery Group PLC SWOT Analysis
2.11.4 Horizon Discovery Group PLC Product and Services
2.11.5 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GlaxoSmithKline plc SWOT Analysis
2.12.4 GlaxoSmithKline plc Product and Services
2.12.5 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.13 Monsanto Company
2.13.1 Monsanto Company Details
2.13.2 Monsanto Company Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Monsanto Company SWOT Analysis
2.13.4 Monsanto Company Product and Services
2.13.5 Monsanto Company Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.14 New England Biolabs.
2.14.1 New England Biolabs. Details
2.14.2 New England Biolabs. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 New England Biolabs. SWOT Analysis
2.14.4 New England Biolabs. Product and Services
2.14.5 New England Biolabs. Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.15 Cibus
2.15.1 Cibus Details
2.15.2 Cibus Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Cibus SWOT Analysis
2.15.4 Cibus Product and Services
2.15.5 Cibus Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Recombinant DNA (rDNA) Technology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Recombinant DNA (rDNA) Technology Players Market Share
3.2.2 Top 10 Recombinant DNA (rDNA) Technology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Recombinant DNA (rDNA) Technology Revenue and Market Share by Regions
4.2 North America Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
4.3 Europe Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
4.5 South America Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
5 North America Recombinant DNA (rDNA) Technology Revenue by Countries
5.1 North America Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
5.2 USA Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
5.3 Canada Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
5.4 Mexico Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
6 Europe Recombinant DNA (rDNA) Technology Revenue by Countries
6.1 Europe Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
6.2 Germany Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
6.3 UK Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
6.4 France Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
6.5 Russia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
6.6 Italy Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Countries
7.1 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
7.2 China Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
7.3 Japan Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
7.4 Korea Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
7.5 India Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
8 South America Recombinant DNA (rDNA) Technology Revenue by Countries
8.1 South America Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
8.2 Brazil Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
8.3 Argentina Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Recombinant DNA (rDNA) Technology by Countries
9.1 Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
9.3 UAE Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
9.4 Egypt Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
9.5 South Africa Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Recombinant DNA (rDNA) Technology Revenue and Market Share by Component (2015-2020)
10.2 Global Recombinant DNA (rDNA) Technology Market Forecast by Component (2019-2024)
10.3 Expression System Revenue Growth Rate (2015-2025)
10.4 Cloning Vector Revenue Growth Rate (2015-2025)
11 Global Recombinant DNA (rDNA) Technology Market Segment by Application
11.1 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2015-2020)
11.2 Recombinant DNA (rDNA) Technology Market Forecast by Application (2019-2024)
11.3 Biotechnology and Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Academic and Government Research Institutes Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Recombinant DNA (rDNA) Technology Market Size Forecast (2021-2025)
12.1 Global Recombinant DNA (rDNA) Technology Market Size Forecast (2021-2025)
12.2 Global Recombinant DNA (rDNA) Technology Market Forecast by Regions (2021-2025)
12.3 North America Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
12.4 Europe Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
12.6 South America Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Recombinant DNA (rDNA) Technology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant DNA (rDNA) Technology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant DNA (rDNA) Technology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Recombinant DNA (rDNA) Technology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Recombinant DNA (rDNA) Technology Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. F. Hoffmann-La Roche Ltd (Genentech, Inc) Corporate Information, Location and Competitors
Table 7. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Major Business
Table 8. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 9. F. Hoffmann-La Roche Ltd (Genentech, Inc) SWOT Analysis
Table 10. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product and Solutions
Table 11. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Eli Lilly and Company Corporate Information, Location and Competitors
Table 13. Eli Lilly and Company Recombinant DNA (rDNA) Technology Major Business
Table 14. Eli Lilly and Company Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2018-2019)
Table 15. Eli Lilly and Company SWOT Analysis
Table 16. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product and Solutions
Table 17. Eli Lilly and Company Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Novartis AG Corporate Information, Location and Competitors
Table 19. Novartis AG Recombinant DNA (rDNA) Technology Major Business
Table 20. Novartis AG Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 21. Novartis AG SWOT Analysis
Table 22. Novartis AG Recombinant DNA (rDNA) Technology Product and Solutions
Table 23. Novartis AG Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Profacgen Corporate Information, Location and Competitors
Table 25. Profacgen Recombinant DNA (rDNA) Technology Major Business
Table 26. Profacgen Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 27. Profacgen SWOT Analysis
Table 28. Profacgen Recombinant DNA (rDNA) Technology Product and Solutions
Table 29. Profacgen Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Novo Nordisk A/S Corporate Information, Location and Competitors
Table 31. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Major Business
Table 32. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 33. Novo Nordisk A/S SWOT Analysis
Table 34. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product and Solutions
Table 35. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Amgen Inc Corporate Information, Location and Competitors
Table 37. Amgen Inc Recombinant DNA (rDNA) Technology Major Business
Table 38. Amgen Inc Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 39. Amgen Inc SWOT Analysis
Table 40. Amgen Inc Recombinant DNA (rDNA) Technology Product and Solutions
Table 41. Amgen Inc Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Biocon Corporate Information, Location and Competitors
Table 43. Biocon Recombinant DNA (rDNA) Technology Major Business
Table 44. Biocon Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 45. Biocon SWOT Analysis
Table 46. Biocon Recombinant DNA (rDNA) Technology Product and Solutions
Table 47. Biocon Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Pfizer Inc Corporate Information, Location and Competitors
Table 49. Pfizer Inc Recombinant DNA (rDNA) Technology Major Business
Table 50. Pfizer Inc Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 51. Pfizer Inc SWOT Analysis
Table 52. Pfizer Inc Recombinant DNA (rDNA) Technology Product and Solutions
Table 53. Pfizer Inc Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. GenScript Corporate Information, Location and Competitors
Table 55. GenScript Recombinant DNA (rDNA) Technology Major Business
Table 56. GenScript Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 57. GenScript SWOT Analysis
Table 58. GenScript Recombinant DNA (rDNA) Technology Product and Solutions
Table 59. GenScript Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Sanofi Corporate Information, Location and Competitors
Table 61. Sanofi Recombinant DNA (rDNA) Technology Major Business
Table 62. Sanofi Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 63. Sanofi SWOT Analysis
Table 64. Sanofi Recombinant DNA (rDNA) Technology Product and Solutions
Table 65. Sanofi Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Horizon Discovery Group PLC Corporate Information, Location and Competitors
Table 67. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Major Business
Table 68. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 69. Horizon Discovery Group PLC SWOT Analysis
Table 70. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product and Solutions
Table 71. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 73. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Major Business
Table 74. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 75. GlaxoSmithKline plc SWOT Analysis
Table 76. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product and Solutions
Table 77. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Monsanto Company Corporate Information, Location and Competitors
Table 79. Monsanto Company Recombinant DNA (rDNA) Technology Major Business
Table 80. Monsanto Company Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 81. Monsanto Company SWOT Analysis
Table 82. Monsanto Company Recombinant DNA (rDNA) Technology Product and Solutions
Table 83. Monsanto Company Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. New England Biolabs. Corporate Information, Location and Competitors
Table 85. New England Biolabs. Recombinant DNA (rDNA) Technology Major Business
Table 86. New England Biolabs. Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 87. New England Biolabs. SWOT Analysis
Table 88. New England Biolabs. Recombinant DNA (rDNA) Technology Product and Solutions
Table 89. New England Biolabs. Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Cibus Corporate Information, Location and Competitors
Table 91. Cibus Recombinant DNA (rDNA) Technology Major Business
Table 92. Cibus Recombinant DNA (rDNA) Technology Total Revenue (USD Million) (2017-2018)
Table 93. Cibus SWOT Analysis
Table 94. Cibus Recombinant DNA (rDNA) Technology Product and Solutions
Table 95. Cibus Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) by Players (2015-2020)
Table 97. Global Recombinant DNA (rDNA) Technology Revenue Share by Players (2015-2020)
Table 98. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Regions (2015-2020)
Table 100. North America Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
Table 101. North America Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Table 102. Europe Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Recombinant DNA (rDNA) Technology Revenue by Countries (2015-2020)
Table 105. South America Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Table 108. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) by Type (2015-2020)
Table 109. Global Recombinant DNA (rDNA) Technology Revenue Share by Type (2015-2020)
Table 110. Global Recombinant DNA (rDNA) Technology Revenue Forecast by Type (2021-2025)
Table 111. Global Recombinant DNA (rDNA) Technology Revenue by Application (2015-2020)
Table 112. Global Recombinant DNA (rDNA) Technology Revenue Share by Application (2015-2020)
Table 113. Global Recombinant DNA (rDNA) Technology Revenue Forecast by Application (2021-2025)
Table 114. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Recombinant DNA (rDNA) Technology Picture
Figure 2. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Component in 2019
Figure 3. Expression System Picture
Figure 4. Cloning Vector Picture
Figure 5. Recombinant DNA (rDNA) Technology Revenue Market Share by Application in 2019
Figure 6. Biotechnology and Pharmaceutical Companies Picture
Figure 7. Academic and Government Research Institutes Picture
Figure 8. Other Picture
Figure 9. Global Recombinant DNA (rDNA) Technology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Recombinant DNA (rDNA) Technology Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Recombinant DNA (rDNA) Technology Revenue Market Share in 2019
Figure 18. Global Top 10 Players Recombinant DNA (rDNA) Technology Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Regions (2015-2020)
Figure 22. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Regions in 2018
Figure 23. North America Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 24. Europe Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 26. South America Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 28. North America Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Figure 29. North America Recombinant DNA (rDNA) Technology Revenue Market Share by Countries in 2019
Figure 30. USA Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 31. Canada Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 33. Europe Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Recombinant DNA (rDNA) Technology Revenue Market Share by Countries in 2019
Figure 35. Germany Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 36. UK Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 37. France Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 38. Russia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 39. Italy Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue Market Share by Countries in 2019
Figure 42. China Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 43. Japan Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 44. Korea Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 45. India Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 47. South America Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Figure 48. South America Recombinant DNA (rDNA) Technology Revenue Market Share by Countries in 2019
Figure 49. Brazil Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 54. UAE Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2015-2020)
Figure 57. Global Recombinant DNA (rDNA) Technology Revenue Share by Type (2015-2020)
Figure 58. Global Recombinant DNA (rDNA) Technology Revenue Share by Type in 2019
Figure 59. Global Recombinant DNA (rDNA) Technology Market Share Forecast by Type (2021-2025)
Figure 60. Global Expression System Revenue Growth Rate (2015-2020)
Figure 61. Global Cloning Vector Revenue Growth Rate (2015-2020)
Figure 62. Global Recombinant DNA (rDNA) Technology Revenue Share by Application (2015-2020)
Figure 63. Global Recombinant DNA (rDNA) Technology Revenue Share by Application in 2019
Figure 64. Global Recombinant DNA (rDNA) Technology Market Share Forecast by Application (2021-2025)
Figure 65. Global Biotechnology and Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 66. Global Academic and Government Research Institutes Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Recombinant DNA (rDNA) Technology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Recombinant DNA (rDNA) Technology Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
Figure 72. Europe Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
Figure 74. South America Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
